{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T18:22:26Z","timestamp":1793989346688,"version":"4.8.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"abstract":"<jats:p>Colorectal cancer (CRC) is a leading global health burden. Systemic lupus erythematosus (SLE) is associated with a higher risk of CRC, but the molecular links between these diseases remain unclear. This study aims to identify key genes that connect SLE to CRC using machine learning approaches. We integrated genomic data from SLE and CRC patients and applied computational methods to uncover shared genetic signatures. Differential expression analysis, weighted gene co-expression network analysis (WGCNA), and machine learning techniques were used to identify hub genes. gene ontology and kyoto encyclopedia of genes and genomes enrichment analyses were performed on shared genes. Additionally, immune infiltration analysis and gene set enrichment analysis were conducted to explore the potential roles of the identified genes. Our analysis revealed 12 shared genes between SLE and CRC, with EPHB2 and TOP2A emerging as key hub genes. EPHB2 and TOP2A were significantly overexpressed in both diseases, suggesting their role in inflammatory and tumorigenic processes. EPHB2 showed excellent diagnostic performance in SLE, while high EPHB2 expression was associated with better overall survival in CRC patients. gene set enrichment analysis identified pathways associated with these hub genes, implicating them in immune response, cell cycle regulation, and DNA replication. Moreover, EPHB2 and TOP2A were found to be associated with immune infiltration in CRC. EPHB2 and TOP2A serve as bridge genes linking SLE and CRC, offering insights into their molecular interplay and the potential for developing new diagnostic markers and therapeutic targets. Future studies should validate these findings and explore the detailed molecular mechanisms.<\/jats:p>","DOI":"10.1097\/md.0000000000044521","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:00:16Z","timestamp":1757970016000},"page":"e44521","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Machine learning identified EPHB2 and TOP2A as key genes linking systemic lupus erythematosus to colorectal cancer"],"prefix":"10.1097","volume":"104","author":[{"given":"Guojiang","family":"Tian","sequence":"first","affiliation":[{"name":"Proctology, Shaoxing People\u2019s Hospital, Shaoxing, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9741-1060","authenticated-orcid":false,"given":"Jianfei","family":"Huang","sequence":"additional","affiliation":[{"name":"Proctology, Shaoxing People\u2019s Hospital, Shaoxing, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260923","doi-asserted-by":"crossref","first-page":"104544","DOI":"10.1016\/j.critrevonc.2024.104544","article-title":"Origin, development and therapy of colorectal cancer from the perspective of a biologist and an oncologist.","volume":"204","author":"Svec","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"R2-20260923","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/cancers16020412","article-title":"Cetuximab as a key partner in personalized targeted therapy for metastatic colorectal cancer.","volume":"16","author":"Saoudi Gonz\u00e1lez","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R3-20260923","doi-asserted-by":"crossref","first-page":"oyae269","DOI":"10.1093\/oncolo\/oyae269","article-title":"Genomic alterations associated with early-stage disease and early recurrence in patients with colorectal cancer.","volume":"30","author":"Pappas","year":"2024","journal-title":"Oncologist"},{"key":"R4-20260923","doi-asserted-by":"crossref","first-page":"1507739","DOI":"10.3389\/fmed.2024.1507739","article-title":"Statin exposure and risk of colorectal cancer in patients with inflammatory bowel disease: a systematic review and meta-analysis.","volume":"11","author":"Li","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R5-20260923","doi-asserted-by":"crossref","first-page":"24786","DOI":"10.1038\/s41598-024-75438-6","article-title":"Integrating machine learning and bioinformatics approaches for identifying novel diagnostic gene biomarkers in colorectal cancer.","volume":"14","author":"Vaziri-Moghadam","year":"2024","journal-title":"Sci Rep"},{"key":"R6-20260923","doi-asserted-by":"crossref","first-page":"1443440","DOI":"10.3389\/fimmu.2024.1443440","article-title":"A review on the novel biomarkers of systemic lupus erythematosus discovered via metabolomic profiling.","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"R7-20260923","doi-asserted-by":"crossref","first-page":"860794","DOI":"10.3389\/fonc.2022.860794","article-title":"Association between systemic lupus erythematosus and cancer morbidity and mortality: findings from cohort studies.","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"R8-20260923","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/medicina58020203","article-title":"Assessment of the RANTES level correlation and selected inflammatory and pro-angiogenic molecules evaluation of their influence on CRC clinical features: a preliminary observational study.","volume":"58","author":"Mielcarska","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"R9-20260923","doi-asserted-by":"crossref","first-page":"1007078","DOI":"10.3389\/fimmu.2022.1007078","article-title":"Dysregulation and chronicity of pathogenic T cell responses in the pre-diseased stage of lupus.","volume":"13","author":"Ohmes","year":"2022","journal-title":"Front Immunol"},{"key":"R10-20260923","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41581-023-00732-x","article-title":"Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants.","volume":"19","author":"Vinuesa","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"R11-20260923","doi-asserted-by":"crossref","first-page":"985729","DOI":"10.3389\/fimmu.2022.985729","article-title":"Exploring causal correlations between inflammatory cytokines and systemic lupus erythematosus: a Mendelian randomization.","volume":"13","author":"Xiang","year":"2022","journal-title":"Front Immunol"},{"key":"R12-20260923","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.ophtha.2023.07.023","article-title":"Use of immunosuppression and the risk of subsequent overall or cancer mortality.","volume":"130","author":"Kempen","year":"2023","journal-title":"Ophthalmology"},{"key":"R13-20260923","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00296-024-05623-3","article-title":"Malignancy in systemic lupus erythematosus: relation to disease characteristics in 92 patients - a single center retrospective study.","volume":"44","author":"Kosa\u0142ka-W\u0119giel","year":"2024","journal-title":"Rheumatol Int"},{"key":"R14-20260923","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/IJGM.S448720","article-title":"Exploring the molecular mechanisms and shared gene signatures between systemic lupus erythematosus and bladder urothelial carcinoma.","volume":"17","author":"Wang","year":"2024","journal-title":"Int J Gen Med"},{"key":"R15-20260923","doi-asserted-by":"crossref","first-page":"1015882","DOI":"10.3389\/fimmu.2022.1015882","article-title":"The shared biomarkers and pathways of systemic lupus erythematosus and metabolic syndrome analyzed by bioinformatics combining machine learning algorithm and single-cell sequencing analysis.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"R16-20260923","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the accuracy of diagnostic systems.","volume":"240","author":"Swets","year":"1988","journal-title":"Science"},{"key":"R17-20260923","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/aje\/kwh101","article-title":"Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.","volume":"159","author":"Pepe","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R18-20260923","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1186\/s12885-024-12843-0","article-title":"Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response.","volume":"24","author":"Xu","year":"2024","journal-title":"BMC Cancer"},{"key":"R19-20260923","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.molonc.2015.02.009","article-title":"Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers.","volume":"9","author":"S\u00f8nderstrup","year":"2015","journal-title":"Mol Oncol"},{"key":"R20-20260923","doi-asserted-by":"crossref","first-page":"995103","DOI":"10.3389\/fmed.2022.995103","article-title":"Potential biomarkers for active renal involvement in systemic lupus erythematosus patients.","volume":"9","author":"Xiao","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R21-20260923","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.3390\/ijms23073620","article-title":"The EPH\/Ephrin system in colorectal cancer.","volume":"23","author":"Papadakos","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R22-20260923","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond.","volume":"10","author":"Pasquale","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R23-20260923","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3389\/fimmu.2019.01473","article-title":"Emerging roles for Eph receptors and ephrin ligands in immunity.","volume":"10","author":"Darling","year":"2019","journal-title":"Front Immunol"},{"key":"R24-20260923","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3892\/mmr.2024.13415","article-title":"Advances in research on malignant tumors and targeted agents for TOP2A (Review).","volume":"31","author":"Zhou","year":"2025","journal-title":"Mol Med Rep"},{"key":"R25-20260923","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41419-021-03798-2","article-title":"UPF1 promotes chemoresistance to oxaliplatin through regulation of TOP2A activity and maintenance of stemness in colorectal cancer.","volume":"12","author":"Zhu","year":"2021","journal-title":"Cell Death Dis"},{"key":"R26-20260923","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41580-022-00452-3","article-title":"Human topoisomerases and their roles in genome stability and organization.","volume":"23","author":"Pommier","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R27-20260923","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/iub.2619","article-title":"Targeting DNA topoisomerase II\u03b1 (TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia-activated prodrugs (uHAPs).","volume":"75","author":"Smith","year":"2023","journal-title":"IUBMB Life"},{"key":"R28-20260923","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12958-022-01013-1","article-title":"TOP2A deficit-induced abnormal decidualization leads to recurrent implantation failure via the NF-\u03baB signaling pathway.","volume":"20","author":"Fu","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"R29-20260923","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1158\/2767-9764.CRC-23-0070","article-title":"PRMT5 inhibitors regulate DNA damage repair pathways in cancer cells and improve response to PARP inhibition and chemotherapies.","volume":"3","author":"Carter","year":"2023","journal-title":"Cancer Res Commun"},{"key":"R30-20260923","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1096\/fj.12-205054","article-title":"EphB2 isolates a human marrow stromal cell subpopulation with enhanced ability to contribute to the resident intestinal cellular pool.","volume":"27","author":"Colletti","year":"2013","journal-title":"FASEB J"},{"key":"R31-20260923","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s13238-011-1058-6","article-title":"EphB2: a signature of colorectal cancer stem cells to predict relapse.","volume":"2","author":"Zhang","year":"2011","journal-title":"Protein Cell"},{"key":"R32-20260923","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1158\/0008-5472.CAN-20-3047","article-title":"Eph receptors in the immunosuppressive tumor microenvironment.","volume":"81","author":"Janes","year":"2021","journal-title":"Cancer Res"},{"key":"R33-20260923","doi-asserted-by":"crossref","first-page":"788587","DOI":"10.3389\/fcell.2022.788587","article-title":"The Roles of EphB2 in Cancer.","volume":"10","author":"Liu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R34-20260923","doi-asserted-by":"crossref","first-page":"e0160283","DOI":"10.1371\/journal.pone.0160283","article-title":"Anti-Ephrin Type-B Receptor 2 (EphB2) and anti-three prime histone mRNA EXonuclease 1 (THEX1) autoantibodies in scleroderma and lupus.","volume":"11","author":"Azzouz","year":"2016","journal-title":"PLoS One"},{"key":"R35-20260923","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.","volume":"441","author":"Kato","year":"2006","journal-title":"Nature"},{"key":"R36-20260923","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-065X.2008.00734.x","article-title":"Function of Nod-like receptors in microbial recognition and host defense.","volume":"227","author":"Franchi","year":"2009","journal-title":"Immunol Rev"},{"key":"R37-20260923","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members.","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"key":"R38-20260923","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus.","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"R39-20260923","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"R40-20260923","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ydbio.2024.02.009","article-title":"Ras\/MAPK signaling mediates adipose tissue control of ovarian germline survival and ovulation in Drosophila melanogaster.","volume":"510","author":"Bradshaw","year":"2024","journal-title":"Dev Biol"},{"key":"R41-20260923","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","article-title":"Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.","volume":"81","author":"Kyriakis","year":"2001","journal-title":"Physiol Rev"},{"key":"R42-20260923","doi-asserted-by":"crossref","first-page":"114609","DOI":"10.1016\/j.fct.2024.114609","article-title":"DEHP induces apoptosis and autophagy of the thyroid via Rap1 signaling pathway: in vivo and in vitro study.","volume":"187","author":"Li","year":"2024","journal-title":"Food Chem Toxicol"},{"key":"R43-20260923","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.3390\/ijms25084570","article-title":"EspP2 regulates the adhesion of glaesserella parasuis via Rap1 signaling pathway.","volume":"25","author":"Tang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R44-20260923","doi-asserted-by":"crossref","first-page":"118754","DOI":"10.1016\/j.jep.2024.118754","article-title":"Tubeimoside-I, an inhibitor of HSPD1, enhances cytotoxicity of oxaliplatin by activating ER stress and MAPK signaling pathways in colorectal cancer.","volume":"336","author":"Wu","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"R45-20260923","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.molimm.2024.04.011","article-title":"Prednisone combined with Dihydroartemisinin attenuates systemic lupus erythematosus by regulating M1\/M2 balance through the MAPK signaling pathway.","volume":"170","author":"Chen","year":"2024","journal-title":"Mol Immunol"},{"key":"R46-20260923","doi-asserted-by":"crossref","first-page":"1463339","DOI":"10.3389\/fphar.2024.1463339","article-title":"Activation of EphrinB2\/EphB2 signaling in the spine cord alters glia-neuron interactions in mice with visceral hyperalgesia following maternal separation.","volume":"15","author":"Guo","year":"2024","journal-title":"Front Pharmacol"},{"key":"R47-20260923","doi-asserted-by":"crossref","first-page":"20487","DOI":"10.1073\/pnas.0811862106","article-title":"Ephrin-B1 and ephrin-B2 mediate EphB-dependent presynaptic development via syntenin-1.","volume":"106","author":"McClelland","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R48-20260923","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1096\/fj.13-247759","article-title":"EphB2 contributes to human naive B-cell activation and is regulated by miR-185.","volume":"28","author":"Yu","year":"2014","journal-title":"FASEB J"},{"key":"R49-20260923","doi-asserted-by":"crossref","first-page":"107900","DOI":"10.1016\/j.phrs.2025.107900","article-title":"Discovery of pan-EphB tyrosine kinase inhibitor for metabolic syndrome sparing EphB3 signaling in mice.","volume":"219","author":"Tareq","year":"2025","journal-title":"Pharmacol Res"},{"key":"R50-20260923","doi-asserted-by":"crossref","first-page":"e2319474122","DOI":"10.1073\/pnas.2319474122","article-title":"Targeting EPHB2\/ABL1 restores antitumor immunity in preclinical models of ependymoma.","volume":"122","author":"Ren","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R51-20260923","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13045-017-0530-z","article-title":"Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.","volume":"10","author":"Megiorni","year":"2017","journal-title":"J Hematol Oncol"},{"key":"R52-20260923","first-page":"4343","article-title":"TOP2A inhibition reverses drug resistance of hepatocellular carcinoma to regorafenib.","volume":"12","author":"Wang","year":"2022","journal-title":"Am J Cancer Res"},{"key":"R53-20260923","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/s41416-024-02632-8","article-title":"PRRX1-TOP2A interaction is a malignancy-promoting factor in human malignant peripheral nerve sheath tumours.","volume":"130","author":"Takihira","year":"2024","journal-title":"Br J Cancer"},{"key":"R54-20260923","doi-asserted-by":"crossref","first-page":"12131","DOI":"10.1073\/pnas.2001760117","article-title":"Topoisomerase II\u03b1 is essential for maintenance of mitotic chromosome structure.","volume":"117","author":"Nielsen","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R55-20260923","doi-asserted-by":"crossref","first-page":"e70077","DOI":"10.1111\/jnc.70077","article-title":"PKG-mediated phosphorylation of TOP2A activates HDAC to drive photoreceptor cell death in rd1 mouse inherited retinal degeneration.","volume":"169","author":"Dong","year":"2025","journal-title":"J Neurochem"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:00:38Z","timestamp":1790186438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":55,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044521","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}